Current Therapeutic Strategies in BRAF|Mutant Metastatic ...
Jump to section: · Oncology · Cardiovascular, Renal and Metabolism · Respiratory & Immunology · Rare Disease · Vaccine & Immune therapies · Other ...
BLA Filed for Dato-DXd for EGFR-Mutant Lung Cancer
... treatment of patients with advanced or metastatic nonsquamous NSCLC. ... therapeutic strategy among this patient population. “Glycan editing ...
... current treatment strategies. Diagnosis. edit. Colon cancer with extensive metastases to the liver. Colorectal cancer diagnosis is performed by sampling ...
How to Approach the Patient With BRAF Mutant Tumor - YouTube
Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma ... Case 2: BRAF-Mutated Metastatic Melanoma. Targeted ...
Full Program - San Antonio Breast Cancer Symposium
Case 4: Selecting treatment for patient with tumor ESR1 mutation ... Session 2: Personalizing CDK 4/6 inhibitor therapy for patients with Metastatic Breast Cancer ...
Datopotamab Deruxtecan New BLA Submitted for Accelerated ...
For patients with tumors that have an EGFR mutation, the established first-line treatment in the metastatic setting is an EGFR-TKI.6 While ...
Program TME 24 | Meetings | AACR
Plenary Session 9: Therapy-induced Changes in Organ-specific Microenvironment and Therapeutic Strategies for Targeting the TME ... metastasis and therapeutic ...
Thus, our findings provide a translational triple therapeutic strategy for this lethal disease. ... mutant mice to cancer metastasis. Within the tumor ...
How Do Novel CRC Blood Tests Fare Against Established Tests?
... strategies of colonoscopy or stool testing (substitution) ... Current and Emerging Therapies in Refractory Metastatic Colorectal Cancer.
R&D/Clinical Trials - Pharmaceutical Executive
Results from the Phase II PHAROS trial found that treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer administered Braftovi in ...
... drug, including ones currently under development. ... Products. ENHERTU® Approved in China as First HER2 Directed Therapy for Patients with HER2 Mutant Metastatic ...
Characterizing and targeting class II/III BRAF alterations - YouTube
classes of BRAF mutations and current treatment options for BRAF-mutant tumors ... Biomarker Driven Treatment of Metastatic Colorectal Cancer.
Adults with unresectable or metastatic gastrointestinal stromal tumor harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations. Learn more.
Canada's Drug Agency | CDA-AMC
To inform decisions about continuously diffused oxygen (CDO) therapy for wound healing, we identified and summarized literature comparing the clinical ...
Mass General Cancer Center Announces 2024 Recipients of Krantz ...
... strategies for overcoming resistance in this difficult-to-treat family of ... therapies targeting cancers that are not currently treatable.
Targeted Therapy-BRAF Inhibitors and Beyond - YouTube
Justin Tyler Moyers MD Assistant Clinical Professor, Division of Hematology/Oncology, Medicine School of Medicine University of California, ...
Celcuity Inc. Reports Third Quarter Financial Results and ... - BioSpace
The PIK3CA wild-type cohort is 100% enrolled, and enrollment in the PIK3CA mutant ... currently approved and investigational therapies that target ...
Combined Neoadjuvant-Adjuvant Immunotherapy and ... - Cureus
A multimodal treatment approach, with the development of specific targeted therapies and immunotherapy, appears to be promising for patients ...
... Treatment of Adult Patients with Recurrent KRAS Mutant ... metastatic pancreatic cancer, is supported by a PanCAN Therapeutic Accelerator Award.
Non-small-cell lung cancer - Wikipedia
Treatment · More than one kind of treatment is often used, depending on the stage of the cancer, the individual's overall health, age, response to chemotherapy, ...